Authorised AIF ICAV
Name:
Sagard Healthcare Royalty Partners ICAV
Reference No:
C405028
Date of Authorisation
11 Dec 2019
Status:
ICAV
Notes:
- This fund may be marketed to Qualifying Investors only in accordance with the Central Bank of Ireland’s AIF Rulebook/NU Notices and therefore a minimum subscription of Euro 100,000 is required.
- This fund was authorised by the Central Bank of Ireland as an open-ended with limited liquidity investment fund.
AIFM:
Reference Number
Name
C72256
Maples Fund Management Ireland Limited
Management Company:
Reference Number
Name
Depositary:
Reference Number
Name
C20900
SMT Trustees (Ireland) Limited
Sub-Funds:
Reference No:
Name
Date of Approval
C475048
Sagard Healthcare Partners Sub-Fund
07 Mar 2022
C475049
Sagard Healthcare Partners Co-Invest Sub-Fund
07 Mar 2022
Page last updated on:
22 Oct 2024